Regulations.gov document
Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Renewal
Notice · FDA-2019-N-4203 · posted Dec 11, 2020
Key facts
| Document ID | FDA-2019-N-4203-0033 |
|---|---|
| Title | Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Renewal |
| Document type | Notice |
| Subtype | Advisory Committee |
| Agency | FDA |
| Docket | FDA-2019-N-4203 |
| Posted | Dec 11, 2020 |
| Federal Register citation | 85 FR 80116 |
| FR document number | 2020-27289 |
| Comment period opens | Dec 11, 2020 |
| Effective date | Dec 11, 2020 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: